Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

NCT05240521 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Devintec Sagl

Collaborators